
Brian E. Mcdowell
Examiner (ID: 5411, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1663 |
| Issued Applications | 1042 |
| Pending Applications | 129 |
| Abandoned Applications | 533 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12204796
[patent_doc_number] => 20180050022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'FACTOR XIa INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/681478
[patent_app_country] => US
[patent_app_date] => 2017-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45526
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15681478
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/681478 | Factor XIa inhibitors | Aug 20, 2017 | Issued |
Array
(
[id] => 12975700
[patent_doc_number] => 20170340650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 15/678381
[patent_app_country] => US
[patent_app_date] => 2017-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15678381
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/678381 | Triterpenoids with HIV maturation inhibitory activity | Aug 15, 2017 | Issued |
Array
(
[id] => 13916543
[patent_doc_number] => 10202379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => Substituted polycyclic carbamoyl pyridone derivative prodrug
[patent_app_type] => utility
[patent_app_number] => 15/676540
[patent_app_country] => US
[patent_app_date] => 2017-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 149834
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1679
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15676540
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/676540 | Substituted polycyclic carbamoyl pyridone derivative prodrug | Aug 13, 2017 | Issued |
Array
(
[id] => 16476184
[patent_doc_number] => 10851112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Anti-HCMV virus compound
[patent_app_type] => utility
[patent_app_number] => 16/323074
[patent_app_country] => US
[patent_app_date] => 2017-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18932
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323074
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/323074 | Anti-HCMV virus compound | Aug 7, 2017 | Issued |
Array
(
[id] => 16696634
[patent_doc_number] => 10947214
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => TLR7/8 antagonists and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/670068
[patent_app_country] => US
[patent_app_date] => 2017-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40205
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15670068
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/670068 | TLR7/8 antagonists and uses thereof | Aug 6, 2017 | Issued |
Array
(
[id] => 12185402
[patent_doc_number] => 20180044338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/669301
[patent_app_country] => US
[patent_app_date] => 2017-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 72703
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15669301
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/669301 | SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS | Aug 3, 2017 | Abandoned |
Array
(
[id] => 12837109
[patent_doc_number] => 20180170876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => NOVEL HISTONE DEACETYLASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/667069
[patent_app_country] => US
[patent_app_date] => 2017-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15667069
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/667069 | Histone deacetylase inhibitors | Aug 1, 2017 | Issued |
Array
(
[id] => 13051441
[patent_doc_number] => 10047101
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-14
[patent_title] => Flap modulators
[patent_app_type] => utility
[patent_app_number] => 15/667420
[patent_app_country] => US
[patent_app_date] => 2017-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52038
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15667420
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/667420 | Flap modulators | Aug 1, 2017 | Issued |
Array
(
[id] => 12185358
[patent_doc_number] => 20180044293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'ASYMMETRIC UREAS AND MEDICAL USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/663761
[patent_app_country] => US
[patent_app_date] => 2017-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21182
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15663761
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/663761 | Asymmetric ureas and medical uses thereof | Jul 29, 2017 | Issued |
Array
(
[id] => 14924499
[patent_doc_number] => 20190297887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => BICYCLIC COMPOUNDS AS PESTICIDES
[patent_app_type] => utility
[patent_app_number] => 16/316455
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 393
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316455
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/316455 | BICYCLIC COMPOUNDS AS PESTICIDES | Jul 9, 2017 | Abandoned |
Array
(
[id] => 12001729
[patent_doc_number] => 20170305884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'PREPARATION METHOD FOR BEMACICLB'
[patent_app_type] => utility
[patent_app_number] => 15/643837
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4222
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15643837
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/643837 | Preparation method for Bemaciclb | Jul 6, 2017 | Issued |
Array
(
[id] => 16383156
[patent_doc_number] => 10807978
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Process for preparation of palbociclib
[patent_app_type] => utility
[patent_app_number] => 16/314972
[patent_app_country] => US
[patent_app_date] => 2017-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 6960
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16314972
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/314972 | Process for preparation of palbociclib | Jul 2, 2017 | Issued |
Array
(
[id] => 14119161
[patent_doc_number] => 10246425
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-02
[patent_title] => 3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds
[patent_app_type] => utility
[patent_app_number] => 15/638175
[patent_app_country] => US
[patent_app_date] => 2017-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 47055
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15638175
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/638175 | 3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds | Jun 28, 2017 | Issued |
Array
(
[id] => 12205796
[patent_doc_number] => 20180051022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'DEUTERATED PALBOCICLIB'
[patent_app_type] => utility
[patent_app_number] => 15/636976
[patent_app_country] => US
[patent_app_date] => 2017-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11814
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15636976
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/636976 | DEUTERATED PALBOCICLIB | Jun 28, 2017 | Abandoned |
Array
(
[id] => 14064301
[patent_doc_number] => 10236457
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-19
[patent_title] => Synthesis of porphyrin materials for highly efficient organic photovoltaics
[patent_app_type] => utility
[patent_app_number] => 15/635563
[patent_app_country] => US
[patent_app_date] => 2017-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 18
[patent_no_of_words] => 11862
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15635563
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/635563 | Synthesis of porphyrin materials for highly efficient organic photovoltaics | Jun 27, 2017 | Issued |
Array
(
[id] => 15363427
[patent_doc_number] => 20200017478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => Compounds And Their Use For Reducing Uric Acid Levels
[patent_app_type] => utility
[patent_app_number] => 16/310950
[patent_app_country] => US
[patent_app_date] => 2017-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310950
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/310950 | Compounds and their use for reducing uric acid levels | Jun 20, 2017 | Issued |
Array
(
[id] => 13702597
[patent_doc_number] => 20170362253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
[patent_app_type] => utility
[patent_app_number] => 15/626496
[patent_app_country] => US
[patent_app_date] => 2017-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2411
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15626496
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/626496 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | Jun 18, 2017 | Abandoned |
Array
(
[id] => 12054711
[patent_doc_number] => 20170331056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'PHOSPHORESCENT TETRADENTATE METAL COMPLEXES HAVING MODIFIED EMISSION SPECTRA'
[patent_app_type] => utility
[patent_app_number] => 15/615566
[patent_app_country] => US
[patent_app_date] => 2017-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 27339
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15615566
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/615566 | Phosphorescent tetradentate metal complexes having modified emission spectra | Jun 5, 2017 | Issued |
Array
(
[id] => 11962022
[patent_doc_number] => 20170266175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'NOVEL PIPERIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 15/612123
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23175
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15612123
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/612123 | Piperidine derivatives | Jun 1, 2017 | Issued |
Array
(
[id] => 11956066
[patent_doc_number] => 20170260217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'METHODS FOR SYNTHESIZING METAL MESOPORPHYRINS'
[patent_app_type] => utility
[patent_app_number] => 15/603654
[patent_app_country] => US
[patent_app_date] => 2017-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9543
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15603654
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/603654 | METHODS FOR SYNTHESIZING METAL MESOPORPHYRINS | May 23, 2017 | Abandoned |